NCT00666796 - A Study to Assess the Pharmacodynamic Interaction Between Gabapentin and Ethanol in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

May 31, 2005

Conditions

Insomnia

Interventions

DRUG

Placebo ethanol

Matched placebo ethanol 0.4% in a total volume of 300 mL as an orange juice cocktail (consumed within 15 minutes) at 1 hour prior to assessment timepoint

DRUG

Ethanol

Ethanol 0.7 g/kg in a total volume of 300 mL as an orange juice cocktail (consumed within 15 minutes) at 1 hour prior to assessment timepoint

DRUG

Placebo

Matched placebo oral capsule with 8 oz of water 2 hours prior to assessment timepoint

DRUG

Gabapentin

Gabapentin 500 mg oral capsule with 8 oz of water 2 hours prior to assessment timepoint

DRUG

Ethanol

Ethanol 0.7 g/kg in a total volume of 300 mL as an orange juice cocktail (consumed within 15 minutes) at 1 hour prior to assessment timepoint

DRUG

Placebo

Matched placebo oral capsule with 8 oz of water 2 hours prior to assessment timepoint

DRUG

Gabapentin

Gabapentin 500 mg oral capsule with 8 oz of water 2 hours prior to assessment timepoint

DRUG

Placebo ethanol

Matched placebo ethanol 0.4% in a total volume of 300 mL as an orange juice cocktail (consumed within 15 minutes) at 1 hour prior to assessment timepoint

Trial Locations (1)

33181

Pfizer Investigational Site, Miami

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY